OneBio Venture Studio Makes Second Investment Into Yemaachi Biotech
OneBio Venture Studio is proud to announce its second investment from Fund II into Yemaachi Biotech, a Ghana-based genomics company building the world’s most diverse cancer bio-database to develop next-generation cancer drugs that work across diverse populations. Yemaachi Biotech‘s work is rooted in a simple but powerful conviction: precision oncology research, diagnostics, and therapeutics must […]
Dr. Yaw Bediako Joins Ashesi as Dean of Research and Innovation
Ashesi University is pleased to welcome Dr. Yaw Bediako as the Dean of Research and Innovation. In this role, he will provide strategic leadership to advance our research initiatives, foster innovation across various academic disciplines, and strengthen partnerships that support Ashesi’s mission. The Dean of Research and Innovation role highlights Ashesi’s commitment to deepening research […]
Bio Usawa and Yemaachi Biotech Unite to Transform HealthCare in Africa.
Diasporan biotech innovators co-develop monoclonal antibodies and genomic-driven solutions tailored for African patients. Kigali, Rwanda and Accra, Ghana — In a landmark collaboration, Bio Usawa, a pioneering biotechnology company building Africa’s monoclonal antibody development and manufacturing capacity, and Yemaachi Biotech, a leader in African cancer genomics, have joined forces to accelerate precision medicine and pharmacogenomics […]
Yemaachi Biotech and Illumina Announce the Arrival of the NovaSeq X Plus in Ghana
At Yemaachi, Bediako is developing cancer diagnostics and treatments tailored to Africans, and he describes the limited official data on patients with cancer across Africa as a major challenge.
Yemaachi Biotechnology Launches The African Cancer Atlas, in Partnership with Roche
Roche has signed as the founding partner to initiate the consortium which will generate genomic and clinical data from up to 7,500 African cancer patients ACCRA, Ghana & WASHINGTON–(BUSINESS WIRE)–Yemaachi Biotech, a pioneering genomics research company based in Ghana, announced today a partnership with Roche to launch The African Cancer Atlas (TACA). This initiative aims […]
Yemaachi and Institut Pasteur Tunis Forge Oncogenetics Partnership to Sequence and Characterise Inflammatory Breast Cancer in Patients of African Descent
Partnership is emblematic of a global effort to characterise cancer development and progression in individuals of African descent, who have traditionally been excluded from genomic oncology studies and clinical trials 22nd October 2024, Tunis, Tunisia — Precision oncology company Yemaachi Biotech and Institut Pasteur Tunis today announced a research partnership investigating genomics in inflammatory breast […]
Oxford Nanopore announces participation in the PROGRESS study, with Yemaachi Biotech
A consortium of Yemaachi Biotech, Pediatric Oncology Units at Korle Bu Teaching Hospital, Komfo Anokye Teaching Hospital and Greater Accra Regional Hospital, and Newcastle University, have come together with Oxford Nanopore to support improved outcomes for childhood leukaemias in Ghana.
Yemaachi Furthers African Cancer Research Agenda With New Breast Cancer Mutation, Research Networks
Yemaachi Biotech is preparing to expand a whole-exome sequencing pilot study, while pushing forward several other pan-African cancer research initiatives.
Yemaachi Presents Findings on Mutation Profiles of Ghanaian Women with Breast Cancer at AORTIC 2023; Announces Formation of African Clinical Cancer Research Network
Results presented in collaboration with Paemka Research Group at the University of Ghana represent largest sequencing study of its kind conducted entirely in Africa to date; Company’s cancer network will advance and scale precision oncology research and collaborations across the continent